Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A

Efforts to develop a vaccine for the elimination of malaria include the use of carrier proteins to assemble monomeric antigens into nanoparticles to maximize immunogenicity. Recombinant ExoProtein A (EPA) is a detoxified form of Pseudomonas aeruginosa Exotoxin A which has been used as a carrier in t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vaccine
Egile Nagusiak: Burkhardt, Martin, Reiter, Karine, Nguyen, Vu, Suzuki, Motoshi, Herrera, Raul, Duffy, Patrick E., Shimp, Richard, MacDonald, Nicholas J., Olano, L. Renee, Narum, David L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6525083/
https://ncbi.nlm.nih.gov/pubmed/30262247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.09.037
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak